Ricky D Shafer

Array ( [id] => 326626 [patent_doc_number] => 07514397 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2009-04-07 [patent_title] => 'Methods for inhibition of membrane-fusion-associated events, including Hepatitis B virus transmission' [patent_app_type] => utility [patent_app_number] => 08/487355 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 83 [patent_figures_cnt] => 84 [patent_no_of_words] => 204321 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 210 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/514/07514397.pdf [firstpage_image] =>[orig_patent_app_number] => 08487355 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3693282 [patent_doc_number] => 05660978 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-26 [patent_title] => 'Stabilization of analytes' [patent_app_type] => 1 [patent_app_number] => 8/483375 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2188 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 172 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/660/05660978.pdf [firstpage_image] =>[orig_patent_app_number] => 483375 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3623839 [patent_doc_number] => 05620846 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-15 [patent_title] => 'Diagnostic and prognostic indices for cancer and aids' [patent_app_type] => 1 [patent_app_number] => 8/478121 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 5790 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/620/05620846.pdf [firstpage_image] =>[orig_patent_app_number] => 478121 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3873239 [patent_doc_number] => 05747242 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-05 [patent_title] => 'Diagnostic kits and methods for detecting antibodies to LAV viruses' [patent_app_type] => 1 [patent_app_number] => 8/466907 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 12442 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 182 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/747/05747242.pdf [firstpage_image] =>[orig_patent_app_number] => 466907 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3621110 [patent_doc_number] => 05601975 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-11 [patent_title] => 'Method for screening potential therapeutically effective antiviral agents' [patent_app_type] => 1 [patent_app_number] => 8/466420 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 26 [patent_no_of_words] => 7405 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/601/05601975.pdf [firstpage_image] =>[orig_patent_app_number] => 466420 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3775005 [patent_doc_number] => 05807992 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-15 [patent_title] => 'HIV-2 transmembrane glycoprotein homodimer (gp 80)' [patent_app_type] => 1 [patent_app_number] => 8/466273 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 20 [patent_no_of_words] => 13163 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/807/05807992.pdf [firstpage_image] =>[orig_patent_app_number] => 466273 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4089952 [patent_doc_number] => 06096315 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-01 [patent_title] => 'Heterofunctional cellular immunological reagents, vaccines containing same and methods for the use of same' [patent_app_type] => 1 [patent_app_number] => 8/469923 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17413 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 156 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/096/06096315.pdf [firstpage_image] =>[orig_patent_app_number] => 469923 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3682859 [patent_doc_number] => 05695762 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-09 [patent_title] => 'Immunodominant sites of HTLV-I envelope protein' [patent_app_type] => 1 [patent_app_number] => 8/466763 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8627 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/695/05695762.pdf [firstpage_image] =>[orig_patent_app_number] => 466763 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1527487 [patent_doc_number] => 06479055 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-12 [patent_title] => 'Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission' [patent_app_type] => B1 [patent_app_number] => 08/470896 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 83 [patent_figures_cnt] => 84 [patent_no_of_words] => 244328 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/479/06479055.pdf [firstpage_image] =>[orig_patent_app_number] => 08470896 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3653309 [patent_doc_number] => 05622703 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-22 [patent_title] => 'Immunodominant sites of HTLV-I envelope protein' [patent_app_type] => 1 [patent_app_number] => 8/469615 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 14 [patent_no_of_words] => 8566 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/622/05622703.pdf [firstpage_image] =>[orig_patent_app_number] => 469615 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4309085 [patent_doc_number] => 06316243 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-13 [patent_title] => 'Genetically engineered attenuated double-stranded RNA viruses' [patent_app_type] => 1 [patent_app_number] => 8/470106 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 17 [patent_no_of_words] => 14568 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/316/06316243.pdf [firstpage_image] =>[orig_patent_app_number] => 470106 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4129619 [patent_doc_number] => 06121002 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-19 [patent_title] => 'Method to detect bone and other connective tissue disorders in humans and animals' [patent_app_type] => 1 [patent_app_number] => 8/486276 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 9794 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/121/06121002.pdf [firstpage_image] =>[orig_patent_app_number] => 486276 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3932010 [patent_doc_number] => 05928930 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-27 [patent_title] => 'Prevention and treatment of retroviral disease' [patent_app_type] => 1 [patent_app_number] => 8/464137 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4908 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/928/05928930.pdf [firstpage_image] =>[orig_patent_app_number] => 464137 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3974385 [patent_doc_number] => 05916806 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-29 [patent_title] => 'Prevention and treatment of retroviral disease' [patent_app_type] => 1 [patent_app_number] => 8/464139 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4938 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/916/05916806.pdf [firstpage_image] =>[orig_patent_app_number] => 464139 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3685418 [patent_doc_number] => 05643716 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-01 [patent_title] => 'Diagnostic agent and methods for identifying HIV infected individuals and monitoring their therapy' [patent_app_type] => 1 [patent_app_number] => 8/465004 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 12 [patent_no_of_words] => 10062 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/643/05643716.pdf [firstpage_image] =>[orig_patent_app_number] => 465004 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3580001 [patent_doc_number] => 05580720 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-03 [patent_title] => 'Human lymphoid cells expressing human immunodeficiency virus envelope protein gp160' [patent_app_type] => 1 [patent_app_number] => 8/460447 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6533 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/580/05580720.pdf [firstpage_image] =>[orig_patent_app_number] => 460447 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3932971 [patent_doc_number] => 05972629 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-26 [patent_title] => 'Method for characterizing antigenic reactivity of biological sample' [patent_app_type] => 1 [patent_app_number] => 8/461583 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 55 [patent_no_of_words] => 36512 [patent_no_of_claims] => 83 [patent_no_of_ind_claims] => 27 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/972/05972629.pdf [firstpage_image] =>[orig_patent_app_number] => 461583 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3991667 [patent_doc_number] => 05985587 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-16 [patent_title] => 'Polypeptide-induced monoclonal receptors to protein ligands' [patent_app_type] => 1 [patent_app_number] => 8/461584 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 26039 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/985/05985587.pdf [firstpage_image] =>[orig_patent_app_number] => 461584 [rel_patent_id] =>[rel_patent_doc_number] =>)